Prognostic Significance of Initial Platelet Counts and Fibrinogen Level in Advanced Non-Small Cell Lung Cancer
Open Access
- 1 January 2014
- journal article
- Published by Korean Academy of Medical Sciences in Journal of Korean Medical Science
- Vol. 29 (4), 507-511
- https://doi.org/10.3346/jkms.2014.29.4.507
Abstract
Thrombocytosis and coagulation systems activation are commonly associated with disease progression and are suggested poor prognostic factors in patients with malignancies. This study aimed to investigate the prevalence and prognostic significance of thrombocytosis and elevated fibrinogen levels in patients with advanced non-small cell lung cancer (NSCLC). Initial platelet counts and fibrinogen levels were reviewed in 854 patients with histologically proven NSCLC. Thrombocytosis was defined as platelet counts > 450 × 109/L. A serum fibrinogen level > 4.5 g/L was considered high. At the time of diagnosis, initial platelet counts and serum fibrinogen levels were evaluated before treatment. Clinicopathologic data including histological type, tumor, node, metastasis (TNM) stage, performance status, treatment method, and survival time were evaluated. Initial thrombocytosis was found in 6.9% of patients, and elevated fibrinogen levels were found in 55.1% of patients. Patients with thrombocytosis had a significantly poorer prognosis than patients with normal platelet counts (P < 0.001). In multivariate survival analysis, thrombocytosis was an independent prognostic factor (P < 0.001). An elevated serum fibrinogen level was associated with poor prognosis (P < 0.001). In conclusion, initial thrombocytosis and a high fibrinogen level are independent factors for predicting poor prognosis in patients with advanced NSCLC.Keywords
This publication has 26 references indexed in Scilit:
- Prognostic impact of thrombocytosis in resectable non-small cell lung cancerInteractive CardioVascular and Thoracic Surgery, 2008
- Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancerLung Cancer, 2006
- Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosisPublished by Oxford University Press (OUP) ,2005
- Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreasThe American Journal of Surgery, 2005
- Prognostic Significance of Thrombocytosis in Node-negative Colon CancerJournal of International Medical Research, 2005
- Thrombocytosis as a Useful Prognostic Indicator in Patients with Lung CancerRespiration, 2004
- Effect of Recombinant Interleukin-6 and Thrombopoietin on Isolated Guinea Pig Bone Marrow Megakaryocyte Protein Phosphorylation and Proplatelet FormationBlood Cells, Molecules, and Diseases, 1997
- Prognostic significance of thrombocytosis in patients with primary lung cancerEuropean Respiratory Journal, 1996
- Macrophage Colony-Stimulating Factor Enhances Platelet Recovery Following Cisplatin/Carboplatin Chemotherapy in Ovarian CancerGynecologic Oncology, 1994
- Fatty acid modulation of tumor cell-platelet-vessel wall interactionCancer and Metastasis Reviews, 1992